<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35538794</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1874-4702</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>10</Day>
            </PubDate>
          </JournalIssue>
          <Title>Current molecular pharmacology</Title>
          <ISOAbbreviation>Curr Mol Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evaluation of the Relationship Between Aromatase/Sirtuin1 Interaction and miRNA Expression in Human Neuroblastoma Cells.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.2174/1874467215666220510112118</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Changes in activation/inhibition of Sirtuin-1 (SIRT1) and aromatase play an important role in a plethora number of diseases. MicroRNAs (miRNAs) modulate multiple molecular pathways and affect a substantial number of physiological and pathological processes Objective: The aim of this study was to investigate any possible interaction between aromatase and SIRT1 in SH-SY5Y cells and to see how there is a connection between this interaction and miRNA expression-if there is an interaction.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">In this study, cells were incubated in serum-deprived media for 6, 12, 24 h. Aromatase and SIRT1 expression were evaluated by Western blot. The IC50 concentration of SIRT1 activator (SRT1720), SIRT1 inhibitor (EX527) and aromatase inhibitors (letrozole and fadrozole) was determined by XTT method. Then, CYP19A1 and SIRT1 levels were evaluated in the presence of SIRT1 siRNA or IC50 values for each activator/inhibitor. Finally, CYP19A1, SIRT1 expression and miRNA target gene analyzes were assessed with bioinformatics approaches.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Aromatase and SIRT1 protein levels were significantly elevated in the cells incubated at 24 h in serum-deprived media (p ≤ 0.05). SIRT1 also positively regulated CYP19A1 in SH-SY5Y cells in media with/without FBS. Serum deprivation depending on time course caused changes in the oxidant/antioxidant system. While oxidative stress index tends to decrease in the absence of FBS at 24 h compared to the control, it showed a significant decrease in the 48 h serum-deprived manner(p ≤ 0.001). As a result of bioinformatic analysis, we determined 3 miRNAs which could potentially regulate the SIRT1 and CYP19A1. hsa-miR-27a-3p and hsa-miR-181a-5p correlated in terms of their expressions at 24 h compared to 12 h, and there was a significant decrease in the expression of these miRNAs. On the contrary, the expression of hsa-miR-30c-5p significantly increased at 24 h compared to 12 h.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">When the results are considered altogether, a direct link between aromatase and SIRT1 was present in human neuroblastoma cells. The identification of key miRNAs; hsa-miR-27a-3p, hsa-miR-30c-5p and hsa-miR-181a-5p targeting both aromatase and SIRT1 provided an approach with novel insights in neurology-associated diseases.</AbstractText>
          <CopyrightInformation>Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kartal</LastName>
            <ForeName>Yasemin</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Department of Physiology, Hacettepe University, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tokat</LastName>
            <ForeName>Unal Metin</ForeName>
            <Initials>UM</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Science, Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kelicen-Ugur</LastName>
            <ForeName>Pelin</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Pharmacy, Department of Pharmacology, Hacettepe University, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yılmaz</LastName>
            <ForeName>Serkan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Nursing, Institute for Forensic Sciences, Ankara University, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Karahan</LastName>
            <ForeName>Sevilay</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Department of Biostatistics, Hacettepe University, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Budak</LastName>
            <ForeName>Murat Timur</ForeName>
            <Initials>MT</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Department of Physiology, Hacettepe University, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>10</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United Arab Emirates</Country>
        <MedlineTA>Curr Mol Pharmacol</MedlineTA>
        <NlmUniqueID>101467997</NlmUniqueID>
        <ISSNLinking>1874-4672</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Aromatase</Keyword>
        <Keyword MajorTopicYN="N">hsa-miR-181a-5p</Keyword>
        <Keyword MajorTopicYN="N">hsa-miR-27a-3p</Keyword>
        <Keyword MajorTopicYN="N">hsa-miR-30c-5p</Keyword>
        <Keyword MajorTopicYN="N">oxidative stress and Sirtuin1</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>3</Hour>
          <Minute>13</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35538794</ArticleId>
        <ArticleId IdType="doi">10.2174/1874467215666220510112118</ArticleId>
        <ArticleId IdType="pii">CMP-EPUB-123308</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
